| 英文别名 |
GDC-0077;GDC0077;Inavolisib;RG6114;L4C1UY2NYH;Ro7113755;(S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide;Inavolisib [USAN];GTPL9636;BDBM295665;AMY16810;NSC800729;US10112932, Compound 101;WHO 11204;DB15275;(2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]be;Propanamide, 2-((2-((4S)-4-(difluoromethyl)-2-oxo-3-oxazolidinyl)-5,6-dihydroimidazo(1,2-d)(1,4)benzoxazepin-9-yl)amino)-, (2S)-;(2S)-2-((2-((4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl)-5,6-dihydroimidazo(1,2-d)(1,4)benzoxazepin-9-yl)amino)propanamide;CS-6459;HY-101562;(2S)-2-({2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}amino)propanamide;UNII-L4C1UY2NYH;N~2~-{(4S,11aP)-2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-L-alaninamide;s8668;SGEUNORSOZVTOL-CABZTGNLSA-N;Inavolisib (USAN/INN);(2S)-2-({4-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-9-oxa-3,6-diazatricyclo[8.4.0.0,tetradeca-1(14),2,4,10,12-pentaen-12-yl}amino)propanamide;RO-7113755;SCHEMBL18360780;(S)-2-((2-((S)-4-(Difluoromethyl)-2-oxooxaZolidin-3-yl)-5,6-dihydrobenZo[f]imidaZo[1,2-d][1,4]oxaZepin-9-yl)propanamide;2060571-02-8;INAVOLISIB [WHO-DD];GDC-0077; RG6114;RO 7113755;MFCD31382124;(2S)-2-({4-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-9-oxa-3,6-diazatricyclo[8.4.0.0(2),?]tetradeca-1(14),2,4,10,12-pentaen-12-yl}amino)propanamide;X3N;(2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide;EX-A2685;GDC 0077;GDC-0077;RG6114;RO-7113755;(S)-2-((2-((S)-4-(difluoromethyl)- 2-oxooxazolidin-3-yl)-5,6- dihydrobenzo[f]imidazo[1,2- d][1,4]oxazepin-9- yl)amino)propanamide;CHEMBL4650215;INAVOLISIB [INN];GDC-0077?;AC-31594;AT36699;(2S)-2-({4-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-9-oxa-3,6-diazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),2,4,10,12-pentaen-12-yl}amino)propanamide;MS-26989;PI3K Inhibitor GDC0077;(2S)-2-((4-((4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl)-9-oxa-3,6-diazatricyclo(8.4.0.0^(2,6))tetradeca-1(14),2,4,10,12-pentaen-12-yl)amino)propanamide;AKOS040741785;D11942;RG 6114;(2S)-2-((2-((4S)-4-(DIFLUOROMETHYL)-2-OXO-3-OXAZOLIDINYL)-5,6-DIHYDROIMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)AMINO)PROPANAMIDE;NSC-800729;RG-6114 |